Clinical trial for the control of water intake of patients undergoing hemodialysis treatment

Oller, Graziella Allana Serra Alves de Oliveira; Oliveira, Marília Pilotto de; Cesarino, Cláudia Bernardi; Teixeira, Carla Regina de Souza; Costa, José Abrão Cardeal da; Kusumota, Luciana

doi:10.1590/1518-8345.2694.3091

Acessibilidade / Reportar erro

Brasil

Revista Latino-Americana de Enfermagem

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Articles • Rev. Latino-Am. Enfermagem 26 • 2018 • https://doi.org/10.1590/1518-8345.2694.3091 copy

Clinical trial for the control of water intake of patients undergoing hemodialysis treatment^* * Paper extracted from doctoral dissertation “Impact of an educational and motivational intervention for control of water intake in patients under hemodialysis therapy” presented to Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, PAHO/WHO Collaborating Centre for Nursing Research Development, Ribeirão Preto, SP, Brazil.

Authorship SCIMAGO INSTITUTIONS RANKINGS

ABSTRACT

Objective:

to analyze the impact of an educational and motivational intervention for patients with a chronic kidney disease, undergoing hemodialysis treatment, on the control of fluid intake during interdialytic periods.

Method:

a quasi-experimental, non-randomized clinical trial with patients from a Nephrological Unit of the State of São Paulo. Participants were included in two groups: Control Group with 106 patients and Intervention Group with 86 patients, totaling 192 participants. The used intervention was an educational and motivational video to control liquid intake, based on the Bandura’s Theory. The measure of control of water intake was the percentage of lost weight, also considered the variable outcome of the research. For the data analysis, descriptive analyses and regression analysis of the Inflated Beta Model were used.

Results:

patients who participated in the intervention had a decrease in the pattern of weight gain in interdialytic periods, with a 3.54 times more chance of reaching the goal of 100% of weight loss when compared to participants from the control group.

Conclusion:

the educational and motivational intervention was effective in reducing the percentage of weight loss in patients undergoing hemodialysis. Brazilian Clinical Trials Registry (ReBEC) under the opinion RBR-4XYTP6.

Descriptors:
Renal Insufficiency, Chronic; Renal Dialysis; Clinical Trial; Health Education; Weight Gain; Nursing

Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo Av. Bandeirantes, 3900, 14040-902 Ribeirão Preto SP Brazil, Tel.: +55 (16) 3315-3451 / 3315-4407 - Ribeirão Preto - SP - Brazil
E-mail: rlae@eerp.usp.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Corresponding Author:
Graziella Allana Serra Alves de Oliveira Oller E-mail: gra_enf@yahoo.com.br

Time	CG* (n=106)						IG^† (n=86)
Time	Minimum	Median	Mean	Maximum	SD^‡	Ideal % of weight loss	Minimum	Median	Mean	Maximum	SD^‡	Ideal % of weight loss
P1	29.55	100.00	94.72	100.00	10.52	0.5849	70.69	96.92	95.18	100.00	6.26	0.4884
P2	50.00	100.00	95.38	100.00	8.46	0.5755	84.21	100.00	96.76	100.00	4.60	0.5814
P3	50.41	100.00	95.73	100.00	8.59	0.6321	83.05	100.00	97.46	100.00	4.42	0.6744
P4	48.76	100.00	95.62	100.00	8.68	0.6321	81.40	100.00	97.08	100.00	4.54	0.6512
P5	49.59	100.00	96.03	100.00	8.38	0.6604	66.67	100.00	98.97	100.00	4.32	0.9186
P6	48.00	100.00	95.86	100.00	8.65	0.6698	71.43	100.00	99.21	100.00	3.35	0.8721
P7	48.03	100.00	95.95	100.00	8.51	0.6321	70.59	100.00	98.90	100.00	3.65	0.8372
P8	49.59	100.00	95.19	100.00	9.31	0.6321	54.84	100.00	98.66	100.00	5.72	0.8953
P9	47.93	100.00	95.53	100.00	9.42	0.6698	81.25	100.00	99.28	100.00	2.49	0.8721
P10	49.59	100.00	95.25	100.00	9.17	0.6226	54.55	100.00	98.24	100.00	5.95	0.8140
P11	47.58	100.00	95.19	100.00	9.12	0.5849	41.18	100.00	98.40	100.00	7.16	0.8837
P12	50.41	100.00	95.39	100.00	9.08	0.6415	71.43	100.00	99.45	100.00	3.18	0.9186
P13	51.67	100.00	95.27	100.00	9.19	0.6132	78.12	100.00	99.13	100.00	3.31	0.8953
P14	47.50	100.00	95.54	100.00	9.11	0.6226	82.35	100.00	99.38	100.00	2.61	0.9302
P15	47.93	100.00	95.41	100.00	9.34	0.6226	75.00	100.00	98.95	100.00	3.74	0.8837
P16	51.61	100.00	95.76	100.00	8.69	0.6415	87.10	100.00	99.54	100.00	2.08	0.9302

Scale Parameters (τ*)	Estimate	Standard error	p-value^‡	τ*	95%^§ CI τ*
(Intercept)	−1.6424	0.4419	0.0002	0.1935	0.0814	0.4601
Weight 2	0.1666	0.2183	0.4454	1.1813	0.7701	1.8119
Weight 3	0.5125	0.2220	0.0210	1.6695	1.0805	2.5796
Weight 4	0.4616	0.2213	0.0371	1.5866	1.0283	2.4481
Weight 5	1.1975	0.2379	0.0000	3.3118	2.0776	5.2791
Weight 6	1.1013	0.2349	0.0000	3.0081	1.8983	4.7669
Weight 7	0.8912	0.2292	0.0001	2.4380	1.5556	3.8209
Weight 8	1.0394	0.2331	0.0000	2.8275	1.7906	4.4650
Weight 9	1.1013	0.2349	0.0000	3.0081	1.8983	4.7669
Weight 10	0.8061	0.2273	0.0004	2.2391	1.4341	3.4958
Weight 11	0.8625	0.2286	0.0002	2.3691	1.5136	3.7080
Weight 12	1.1329	0.2358	0.0000	3.1047	1.9555	4.9291
Weight 13	0.9791	0.2315	0.0000	2.6620	1.6912	4.1900
Weight 14	1.1013	0.2349	0.0000	3.0081	1.8983	4.7669
Weight 15	0.9791	0.2315	0.0000	2.6620	1.6912	4.1900
Weight 16	1.1650	0.2368	0.0000	3.2058	2.0153	5.0997
Group IG^\|\|	1.2642	0.1097	0.0000	3.5404	2.8555	4.3895
Self-efficacy	−0.0369	0.0078	0.0000	0.9638	0.9492	0.9787
Confrontation Factor (FLCSI^¶)	0.7270	0.0830	0.0000	2.0689	1.7582	2.4345
Escape-Avoidance Factor (FLCSI^¶)	−0.1924	0.0609	0.0016	0.8250	0.7321	0.9296
Problem solving factor (FLCSI^¶)	0.2868	0.0855	0.0008	1.3322	1.1265	1.5753
Positive Reevaluation Factor (FLCSI^¶)	−0.3789	0.1078	0.0004	0.6846	0.5542	0.8457
Resilience	0.0200	0.0032	0.0000	1.0203	1.0138	1.0267
Symptoms of Anxiety	−0.0399	0.0168	0.0179	0.9609	0.9297	0.9931